July/August 2013

Editor's Page

Robert L. Avery, MD, and Allen C. Ho, MD

Saving Sight Explores the Achievements and Struggles of Heroes in Ophthalmology

Rachel M. Renshaw, Editor-in-Chief

Postoperative Positioning After Macular Hole Surgery

Giulio Bamonte, MD

Public Policy: Shaping Physician Workforce Trends

An impending shortage of specialists must be addressed as the prevalence of age-related diseases increases.

Robert A. Copeland Jr., MD

Ongoing Trials for AMD

Aron Shapiro and Ashley Lafond

Making the Most of Retina Meetings

How a few days can accelerate the first few years of your career.

John D. Pitcher III, MD

Macular Buckle for Retinal Detachment Related to Macular Hole in Highly Myopic Eyes

Old idea, new interest?

Carlos Mateo, MD

Early Experience With Iluvien for the Treatment of Chronic DME

Fluocinolone acetonide implants are a valuable addition to the limited treatment options available for these patients.

Vera K. Schmit-Eilenberger, MD, and Albert J. Augustin, MD

Vitreomacular Traction From a Preretinal Granuloma

Steven Yeh, MD, and Sonia Mehta, MD

Spontaneous Resolution of Uveal Effusion Simulating Choroidal Melanoma

Nevil Ghodasara, BS; Swathi Kaliki, MD; and Carol L. Shields, MD

Suprachoroidal Steroid Delivery

Enforcing our management for refractory macular edema.

Ehab N. El Rayes, MD, PhD

Drug Delivery to the Posterior Segment: An Update

Many routes for sustained drug delivery to the retina are in use or being explored.

David S. Boyer, MD

Dendrimers as Vehicles for Intravitreal Drug Delivery

These nanoparticles can selectively localize within activated retinal microglia, ferrying drugs to fight inflammation.

Raymond Iezzi, MD, MS, and Rangarmanujam M. Kannan, PhD

Challenges of Trial Design for Extended Drug Delivery

A virtual round table with industry.

With Yehia Hashad, MD (Allergan); Ken Green, PhD (Alimera Sciences); and Roman Rubio, MD (Genentech)

Micropulse Laser Therapy for the Treatment of Radiation Retinopathy

This option fills a gap where there is no current standard of care.

Timothy G. Murray, MD, MBA, FACS

Correlation Between Changes in OCT and Visual Acuity in the Management of Neovascular AMD

Does subretinal fluid matter?

David M. Brown, MD

Targeting the Underlying Causes of Retinal Disease

Potential applications for enzymatic manipulation of the vitreous.

Michael Trese, MD

5Q With Philip J. Ferrone, MD

Dr. Ferrone is an ophthalmologist at Long Island Vitreoretinal Consultants in New York.